文献速递创伤与烧伤消化、代谢与肾脏急症

美国创伤外科协会肾损伤器官损伤评分修订建议:多机构泌尿生殖创伤研究的二次分析

Proposed revision of the American Association for Surgery of Trauma Renal Organ Injury Scale: Secondary analysis of the Multi-institutional Genitourinary Trauma Study.
PubMed 文献 · J Trauma Acute Care Surg · 2024-01-29
一句话结论修订版肾创伤分级系统对需止血干预的预测能力优于2018版AAST OIS(AUC 0.883 vs 0.805,p=0.001)。

本研究为多中心回顾性研究的二次分析,纳入2013至2018年七家一级创伤中心549例高级别肾创伤患者(2018版AAST III级52%、IV级45%、V级3%),按修订标准重新分级。修订后60%患者降级、4%升级,其中IV级降为III级者占69.5%,V级降为IV级者占2.8%。修订分级系统对肾出血干预的预测准确性优于2018版AAST OIS(AUC 0.883 vs 0.805,p=0.001),去除尿路损伤因素后预测能力无差异。结论认为修订系统能更好地界定需止血干预的需求。

要点

  • 修订版肾创伤分级对需肾出血干预的预测AUC为0.883,优于2018版AAST OIS的0.805(p=0.001)。
  • 应用修订标准后60%(329/549)患者降级,4%(23/549)升级;IV级降为III级者占69.5%(173例),V级降为IV级者占2.8%(7例)。
  • 549例高级别肾创伤中12%(64例)接受了肾出血干预,89%为钝性损伤。
  • 从修订系统中去除尿路损伤因素后,对肾出血干预的预测能力无差异。
  • 修订分级系统对24小时内输注浓缩红细胞单位数的预测能力也有改善。

适用人群与场景

  • 2013至2018年七家一级创伤中心收治的高级别肾创伤患者,依据2018版AAST OIS分级为III至V级且具备计算机断层扫描(CT)图像。
  • 549例中III级52%(284例)、IV级45%(249例)、V级3%(16例);89%(491例)为钝性损伤。

诊断标准与关键阈值

  • 以2018版AAST肾损伤器官损伤评分(OIS)III至V级作为原始分级标准。
  • 修订分级标准基于肾出血干预的循证标准重新划分损伤等级,具体条目原文未逐条列出。

研究设计与关键结果

  • 研究类型:多中心回顾性研究的二次分析,纳入七家一级创伤中心549例高级别肾创伤患者。
  • 主要终点为肾出血干预;12%(64/549)患者接受了肾出血干预。
  • 修订分级预测肾出血干预的AUC为0.883,2018版AAST OIS为0.805(p=0.001)。
  • 修订分级对24小时内输注浓缩红细胞单位数的预测能力亦有改善。
  • 去除尿路损伤因素后,修订系统对肾出血干预的预测能力无差异。
  • 次要终点包括尿外渗干预和死亡率,原文未报告其具体结果数值。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究的二次分析;证据等级:诊断性试验/标准,Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,修订版肾创伤分级系统比现行AAST OIS肾创伤分级系统能更好地界定需止血干预的需求。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: This study updates the American Association for the Surgery of Trauma (AAST) Organ Injury Scale (OIS) for renal trauma using evidence-based criteria for bleeding control intervention.

METHODS: This was a secondary analysis of a multicenter retrospective study including patients with high-grade renal trauma from seven level 1 trauma centers from 2013 to 2018. All eligible patients were assigned new renal trauma grades based on revised criteria. The primary outcome used to measure injury severity was intervention for renal bleeding. Secondary outcomes included intervention for urinary extravasation, units of packed red blood cells transfused within 24 hours, and mortality. To test the revised grading system, we performed mixed-effect logistic regression adjusted for multiple baseline demographic and trauma covariates. We determined the area under the curve (AUC) to assess accuracy of predicting bleeding interventions from the revised grading system and compared this to 2018 AAST OIS.

RESULTS: Based on the 2018 OIS grading system, we included 549 patients with AAST grades III to V injuries and computed tomography scans (III, 52% [n = 284]; IV, 45% [n = 249]; and V, 3% [n = 16]). Among these patients, 89% experienced blunt injury (n = 491), and 12% (n = 64) underwent intervention for bleeding. After applying the revised grading criteria, 60% (n = 329) of patients were downgraded, and 4% (n = 23) were upgraded; 2.8% (n = 7) downgraded from grade V to IV, and 69.5% (n = 173) downgraded from grade IV to III. The revised renal trauma grading system demonstrated improved predictive ability for bleeding interventions (2018 AUC, 0.805; revised AUC, 0.883; p = 0.001) and number of units of packed red blood cells transfused. When we removed urinary injury from the revised system, there was no difference in its predictive ability for renal hemorrhage intervention.

CONCLUSION: A revised renal trauma grading system better delineates the need for hemostatic interventions than the current AAST OIS renal trauma grading system.

LEVEL OF EVIDENCE: Diagnostic Test/Criteria; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Matta R, Keihani S, Hebert KJ, et al. Proposed revision of the American Association for Surgery of Trauma Renal Organ Injury Scale: Secondary analysis of the Multi-institutional Genitourinary Trauma Study. J Trauma Acute Care Surg. 2024. PMID: 38319246. doi:10.1097/TA.0000000000004232

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。